Earnings per share for the last twelve months: Serina Therapeutics Inc (SER)

Public company logo of Serina Therapeutics, Inc. (SER)

The growth of Serina Therapeutics, Inc. (SER) is based on the validation of extended-release delivery systems for Parkinson's disease drugs and patent protection. The current trailing 12-month EPS helps filter out market noise, with -1.76 serving as the current metric level. Serina Therapeutics, Inc. (SER) develops brain therapies through partnerships with scientific centers, relying on strict FDA standards and capital inflows from Big Pharma.

SER Serina Therapeutics, Inc. Net earnings per one share for the last twelve months (03/28/2024 - 11/18/2026)

Analytical breakdowns and data insights for company Serina (SER)

- company stock exchange capitalization indicators:
Comprehensive company analysis:Serina Pharma - SER
Mass-produced product of Serina Therapeutics Inc

Fundamental analysis requires an assessment of the actual yield of each security. This indicator measures the total annual net income divided by the total number of shares outstanding. By analyzing the 12-month net income per share chart, an investor determines the efficiency of the business capitalization. For Serina Therapeutics, Inc. (SER), this metric confirms financial stability while optimizing polymer supply chains. The diversification of laboratories minimizes operational risks, directly impacting the final profitability.

Main competitors

Jazz Pharmaceuticals Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytokinetics Inc|PTCT (PTC Therapeutics Inc) - Net earnings per share for the last 12 months|Scholar Rock Inc. (SRRK) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Centessa Pharmaceuticals|Net earnings per one share for the last twelve months dyne-tx.com DYN|Earnings per share for the last twelve months Edgewise Corp (EWTX)|RAPP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Alumis Corp ALMS|Zevra Corp - Earnings per share for the last twelve months|CTNM - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Larimar Therapeutics|CAPR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Entrada TRDA|Net earnings per share for the last 12 months PTHS|Net earnings per one share for the last twelve months medicinova.com MNOV|Net earnings per share (EPS TTM) BTAI|PMN (ProMIS Neurosciences Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Apimeds Pharmaceuticals, Inc. APUS|AEON Biopharma (AEON) - Net earnings per one share for the last twelve months|NLSP - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Bionomics|HUGE (FSD Pharma) - Net earnings per share for the last 12 months|RETA: Earnings per share for the last four quarters